Needham & Company Reiterates a 'Buy' on Varian Medical (VAR); Headwinds Lower Numbers

July 26, 2012 9:39 AM EDT Send to a Friend
Needham & Company reiterates a 'Buy' on Varian Medical (NYSE: VAR) price target of $73.00 (from $79.00).

Analyst, Dalton ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login